Related Experiment Video
Updated: Jan 29, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
Novel Antiplatelet Therapies for Atherothrombotic Diseases
Arjun Majithia1, Deepak L Bhatt1
1From the Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, MA.
Insights
Antiplatelet therapies prevent atherothrombotic events but increase bleeding risk. Novel therapies targeting new pathways could improve efficacy while preserving hemostasis for better patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Thrombosis Research
Background:
- Antiplatelet therapies are crucial for managing atherothrombotic diseases.
- Current strategies face limitations due to increased bleeding risk.
- Atherothrombotic diseases affect cardiovascular, cerebrovascular, and peripheral arteries.
Purpose of the Study:
- To explore novel antiplatelet therapies.
- To identify strategies that maintain efficacy while minimizing bleeding.
- To improve outcomes in patients with atherothrombotic conditions.
Main Methods:
- Review of existing antiplatelet mechanisms.
- Analysis of signaling pathways involved in platelet aggregation and hemostasis.
- Exploration of potential targets for novel drug development.
Main Results:
- Intensifying current antiplatelet regimens increases bleeding risk.
- Novel therapies targeting additional pathways are under development.
- Balancing antiplatelet efficacy and hemostasis is key.
Conclusions:
- Novel antiplatelet agents hold promise for improved atherothrombotic disease management.
- Targeting distinct receptor and signaling pathways may enhance safety.
- Further research is needed to develop and validate new antiplatelet strategies.
Abstract:
Antiplatelet therapies are an essential tool to reduce the risk of developing clinically apparent atherothrombotic disease and are a mainstay in the therapy of patients who have established cardiovascular, cerebrovascular, and peripheral artery disease. Strategies to intensify antiplatelet regimens are limited by concomitant increases in clinically significant bleeding. The development of novel antiplatelet therapies targeting additional receptor and signaling pathways, with a focus on maintaining antiplatelet efficacy while preserving hemostasis, holds tremendous potential to improve outcomes among patients with atherothrombotic diseases.
Related Concept Videos
Gene Therapy
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Group Therapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...

